Adherence study in COPD patients

Trial Identifier: D589CL00003
Sponsor: AstraZeneca
Collaborator:
Quintiles, Inc.
NCTID:: NCT02864342
Start Date: August 2016
Primary Completion Date: October 2017
Study Completion Date: October 2017
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, FL Clearwater, FL, United States of America, 37765
United States of America, FL Tampa, FL, United States of America, 33603
United States of America, NC Charlotte, NC, United States of America, 28207
United States of America, NC Huntersville, NC, United States of America, 28078
United States of America, NJ Marlton, NJ, United States of America, 08053
United States of America, NY Brooklyn, NY, United States of America, 11229
United States of America, PA Downingtown, PA, United States of America, 19335
United States of America, PA Philadelphia, PA, United States of America, 19140
United States of America, SC Spartanburg, SC, United States of America, 29303
United States of America, VA Richmond, VA, United States of America, 23225